Severe Yersinia enterocolitica sepsis after blood transfusion

Netherlands Journal of Medicine

Volumn 65, Issue 8, 2007, Pages 301-303

  Hoelen, D W M ^a   Tjan, D H T ^a   Schouten, M A ^a   Dujardin, B C G ^a   van Zanten, A R H ^a  

^a GELDERSE VALLEI HOSPITAL   (Netherlands)

Author keywords

Adverse events; Blood Transfusion; Contamination; Sepsis; Yersinia enterocolitica

Indexed keywords

BACTERIAL DNA; BACTERIUM ANTIBODY; CEFOTAXIME; CIPROFLOXACIN; CORTICOSTEROID; DOPAMINE; FRESH FROZEN PLASMA; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; NORADRENALIN;

ACUTE LUNG INJURY; ADULT; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CLOTTING DISORDER; BLOOD CULTURE; BLOOD TRANSFUSION; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; DNA DETERMINATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERYTHROCYTE CONCENTRATE; FECES CULTURE; FEVER; HEMATOTHORAX; HEMOGLOBINOPATHY; HEMORRHAGIC SHOCK; HUMAN; HYPOTENSION; INTENSIVE CARE; INTUBATION; KIDNEY FAILURE; LIVING DONOR; MALE; MULTIPLE ORGAN FAILURE; NONHUMAN; PERIOPERATIVE PERIOD; PLEURA EFFUSION; PLEURECTOMY; PNEUMOTHORAX; POSTOPERATIVE PERIOD; RESUSCITATION; SEPSIS; SEROLOGY; THORACOSCOPY; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; WESTERN BLOTTING; YERSINIA ENTEROCOLITICA;

ADULT; BLOOD TRANSFUSION; HUMANS; MALE; RISK FACTORS; SEPSIS; SICKNESS IMPACT PROFILE; YERSINIA ENTEROCOLITICA; YERSINIA INFECTIONS;

EID: 34948900310     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999;340(6):409-17.
2. Beckers EAM, Dinkelaar RB, te Boekhorst PAW, van Ingen HE, van Rhenen DJ. Reports of transfusion incidents: experiences from the first year of haemovigilance in the region of the former ZWN(South West Netherlands) blood bank in Rotterdam. Meldirigen over transfusie-incidenten: ervaringen in het eerste jaar van hemovigilantie in de regio van de voormalige Bloedbank ZWN Rotterdam. Ned Tijdschr Geneeskd 2003;147(31):1508-12.
3. Levy MM, Fink MP, Marshall JC, et al. International Sepsis Definitions Conference. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003;29(4):530-8.
4. Davenport RD. Pathophysiology of haemolytic transfusion reactions. Semin Hematol 2005;42(3):165-8.
5. CBO Richtlijn bloedtransfusie 2004. Bloedwijzer deel 1. Erythrocyten. Thrombocyten. Vers bevroren plasma. Stichting Sanquin. www.sanquin.nl.
6. Kuehnert MJ, Roth VR, Haley NR, et al. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion 2001;41(12);1493-9.
7. Gottlieb T. Hazards of bacterial contamination of blood products. Anaesth Intensive Care 1993;21(1);20-3.
8. Orozova P, Markova N, Radoucheva T. Properties of Yersinia enterocolica and Yersinia pseudotuberculosis in red blood cell concentrate of different ABO groups during 30-day storage at 4 degrees C. Clin Microbiol Infect 2001;7(7):358-61.
9. Carniel E, Mazigh D, Mollaret HH. Expression of iron-regulated proteins in Yersinia species and their relation to virulence. Infect Immun 1987;55(1):277-80.
10. Arduino MJ, Bland LA, Tipple MA, et al. Growth and endotoxin production of Yersinia enterocolitica and Enterobacter agglomerans in packed erythryocytes. J Clin Microbiol 1989;27:1483.
11. Mandell GL, Bennett JE, Dolin R. Principles and practice of Infectious diseases. 6th edition. London: Elsevier, 2005.
12. http://www.rivm.nl/infectieziektenbulletin. De naoorlogse geschiedenis van Yersinia enterocolitica in Nederland. Infectieziekten Bulletin 16.07 2005.
13. Sen K. Rapid identification of Yersinia enterocolica in blood by the nuclease PCR assay. J Clin Microbiol 2000;38(5):1953-8.
14. Janssen MP, van der Poel CL, Buskens E, et al. Costs and benefits of bacterial culturing and pathogen reduction in the Netherlands. Transfusion 2006;46(6):956-65.